CE marking Consultancy for Medical devices under MDR Class IIi. CE marking registration process for High-risk Medical devices under MDR (EU) 2017/745

Regulations of the European Union for categories products and goods required by CE Marking

CE Marking Registration Process for High-Risk Medical Devices under MDR (EU) 2017/745

In the context of increasingly stringent European Union (EU) regulatory requirements for medical devices under:

Medical Device Regulation – MDR (EU) 2017/745,

manufacturers and exporters of medical devices entering the European market are facing significantly stricter technical and legal compliance obligations than before.

Particularly for:

MDR Class III medical devices,

these products are classified as:

high-risk medical devices,
subject to rigorous conformity assessment procedures,
and mandatory review by an EU Notified Body prior to obtaining CE Marking certification.

Failure to fully comply with MDR requirements may result in:

rejection from the EU market,
product recalls,
suspension of market access,
or significant legal liabilities.

WHAT IS MDR CLASS III?

Under MDR (EU) 2017/745, medical devices are classified according to risk level:

Class I
Class IIa
Class IIb
Class III

Among them:

MDR Class III

represents:

the highest-risk category of medical devices.

EXAMPLES OF MDR CLASS III MEDICAL DEVICES

Examples include:

Artificial heart valves
Long-term implantable devices
Neurostimulators
Cardiovascular support devices
Orthopedic implants
Active implantable medical devices
Vascular stents
Devices in direct contact with the central nervous system
Certain high-risk medical software
Devices incorporating medicinal substances or biological materials

WHAT IS CE MARKING FOR MEDICAL DEVICES?

CE Marking is a mandatory conformity mark required for many products entering the EU market.

For medical devices:

CE Marking demonstrates that the product:

complies with MDR (EU) 2017/745,
is safe and effective,
meets clinical performance requirements,
and fulfills all applicable European regulatory obligations.

Without CE Marking:

the product CANNOT legally enter the EU market.

HOW DOES MDR DIFFER FROM THE OLD MDD?

The new MDR imposes significantly stricter requirements than the previous:

Medical Device Directive (MDD 93/42/EEC)

Major changes include:

✅ Increased Clinical Evaluation requirements

✅ Enhanced Post-Market Surveillance (PMS) obligations

✅ Stronger UDI and traceability controls

✅ Expanded ISO 14971 risk management requirements

✅ Increased ISO 10993 biocompatibility evaluation requirements

✅ Greater responsibilities for manufacturers and EU Authorized Representatives

✅ More robust clinical evidence expectations

✅ Stricter Notified Body oversight

✅ More rigorous software medical device regulation

KEY REQUIREMENTS FOR MDR CLASS III CE MARKING

1. DEVICE CLASSIFICATION

Manufacturers must determine:

intended use,
operating principle,
duration of body contact,
invasiveness,
and MDR classification rules.

Incorrect classification:

is one of the most common reasons for application rejection.

2. IMPLEMENTATION OF ISO 13485

For MDR Class III devices:

implementation of:

ISO 13485:2016

is practically mandatory.

ISO 13485 helps manufacturers control:

design and development,
change management,
supplier management,
CAPA,
traceability,
technical documentation,
and medical device lifecycle management.

3. RISK MANAGEMENT ACCORDING TO ISO 14971

MDR Class III devices require:

a complete Risk Management File (RMF)

in accordance with:

ISO 14971.

This includes:

Hazard Identification
Risk Analysis
Risk Evaluation
Risk Control
Residual Risk Evaluation
Benefit-Risk Analysis

This is a critical component of the Technical Documentation.

4. BIOCOMPATIBILITY EVALUATION – ISO 10993

For devices that contact the human body:

implants,
catheters,
blood-contact devices,
implantable materials,

manufacturers must conduct:

Biocompatibility Evaluation

according to:

ISO 10993 series.

5. CLINICAL EVALUATION REPORT (CER)

This is one of the most critical requirements for MDR Class III.

Manufacturers must:

collect clinical data,
evaluate safety,
assess performance,
and demonstrate clinical benefits.

CER is generally prepared in accordance with:

MEDDEV 2.7/1 Rev.4

and MDR Annex XIV.

6. POST-MARKET SURVEILLANCE (PMS)

After market placement, manufacturers must maintain:

PMS Plans,
PMCF,
Vigilance Systems,
Complaint Handling,
Trend Reporting.

These are mandatory requirements under MDR.

7. TECHNICAL DOCUMENTATION

Technical Documentation for MDR Class III typically includes:

✅ Device Description

✅ Intended Use

✅ Design & Manufacturing Information

✅ GSPR Checklist

✅ Risk Management File

✅ Clinical Evaluation Report

✅ Verification & Validation Reports

✅ Biocompatibility Documentation

✅ Sterilization Validation

✅ Software Validation

✅ Labeling & IFU

✅ PMS Documentation

8. NOTIFIED BODY ASSESSMENT

For MDR Class III:

involvement of a Notified Body is MANDATORY.

The Notified Body will:

audit ISO 13485 compliance,
review Technical Documentation,
assess CER,
evaluate PMS systems,
and determine MDR conformity.

Once approved:
the manufacturer may obtain:

CE Certification

and legally affix:

the CE Marking symbol.

MDR CLASS III CE MARKING CONSULTANCY PROCESS

Step 1:

Gap Analysis & MDR Classification

Step 2:

ISO 13485 System Implementation

Step 3:

Risk Management Establishment

Step 4:

Technical Documentation Preparation

Step 5:

Clinical Evaluation & Product Testing

Step 6:

Internal Audit & MDR Readiness

Step 7:

Notified Body Assessment

Step 8:

CE Certification & EU Market Access

COMMON CHALLENGES FACED BY MANUFACTURERS

Manufacturers of MDR Class III devices often face challenges related to:

MDR classification,
Clinical Evaluation,
Technical Documentation,
Risk Management,
selection of suitable Notified Bodies,
lengthy review timelines,
and shortage of MDR specialists.

In addition:
MDR certification costs have significantly increased due to:

limited Notified Body availability,
stricter review processes,
and substantially higher clinical evidence requirements compared to the former MDD framework.

MDR & MEDICAL DEVICE REGULATORY TRENDS IN 2026

Emerging EU regulatory trends increasingly focus on:

AI Medical Devices
Cybersecurity
Software Validation
UDI & EUDAMED
Sustainability
Post-market clinical evidence
Real-world evidence
Digital health compliance

Therefore:
early MDR preparation during product design and development is essential to:

reduce compliance costs and accelerate EU market entry.

VINTECOM INTERNATIONAL

CE Marking – MDR – ISO 13485 – Medical Device Consultancy

VINTECOM International supports manufacturers with:

MDR Classification
CE Marking Consultancy
ISO 13485 Implementation
ISO 14971 Risk Management
Clinical Evaluation
Technical Documentation
GSPR Checklist
MDR Readiness
Internal Audits
Notified Body Coordination Support

For:

medical devices,
medical consumables,
IVD devices,
implants,
electrical medical equipment,
medical software,
laboratory equipment,
and global medical supply chains.

VINTECOM International supports manufacturers, OEM/ODM suppliers, exporters, and FDI enterprises in achieving EU regulatory compliance for international market access.

Organizations and enterprises desire register of certification CE Marking, please contact:

📶📶📶 Contact to register for Training and Consulting services for CE marking or EU Rohs Directive & Reach Directive

Customers, organizations and enterprises require the Training course, Consulting or Audit services of CE marking or EU Rohs Directive & Reach Directive please click on "Registration - Quotation" or on the right toolbar below the PC screen to receive a quotation for Training, Consulting and Certification services.

📶📶📶 Further information, Please contact us as below:

☎ VINTECOM International Office in Ha Noi City: 16th Floor - Green Stars City, 234 Pham Van Dong Street, Phu Dien Ward, Hanoi City. Hotline 094-886-5288/ (024) 730-588-58

☎ VINTECOM International Office in Ho Chi Minh City: Glory Height Vinhome Grand Park - 88 Phuoc Thien Street, Long Binh Ward, HCM City. Hotline 0938-083-998/ (028) 7300-7588

VINTECOM INTERNATIONAL MANAGEMENT CONSULTANCY COMPANY

Head Office: No. 5 Hoang Sam treet, Nghia Do, Cau Giay district, Ha noi City

HANOI VINTECOM INTERNATIONAL OFFICE

Address: 16th Floor - Green Stars City

234 Pham Van Dong Street, Phu Dien Ward, Hanoi City

Tel : (024) 730.588.58/ (024) 730.333.86

Hotline: 094 886 5288

Skype: kd.vintecom

Email : office-hn@vintecom.com.vn

Web : www.vintecom.com.vn

HCM VINTECOM INTERNATIONAL OFFICE

Address : Glory Heights - Vinhomes Grand Park